nifedipine has been researched along with thimerosal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gillespie, JI; Greenwell, JR; Nicholls, JA | 1 |
Evans, RJ; Gachet, C; Gurung, IS; Leon, C; Mahaut-Smith, MP; Martinez-Pinna, J; Vial, C | 1 |
2 other study(ies) available for nifedipine and thimerosal
Article | Year |
---|---|
Agonist concentration influences the pattern and time course of intracellular Ca2+ oscillations in human arterial smooth muscle cells.
Topics: Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Histamine; Humans; Inositol; Muscle, Smooth, Vascular; Nifedipine; Thimerosal; Time Factors; Verapamil | 1995 |
Direct voltage control of signaling via P2Y1 and other Galphaq-coupled receptors.
Topics: Adenosine Diphosphate; Aluminum Compounds; Animals; Calcium; Calcium Channels, L-Type; Calcium Signaling; Diglycerides; Enzyme Activation; Fluorides; GTP-Binding Protein alpha Subunits, Gq-G11; Inositol 1,4,5-Trisphosphate; Ion Channel Gating; Male; Megakaryocytes; Membrane Potentials; Mice; Mice, Inbred C57BL; Nifedipine; Phospholipase C gamma; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Signal Transduction; Thimerosal; Type C Phospholipases | 2005 |